Metabolomic Alterations of Volatile Organic Compounds and Bile Acids as Biomarkers of Microbial Shifts in a Murine Model of Short Bowel Syndrome
Authors:
- Vanessa WolfschlucknerVWVanessa Wolfschluckner
- Beate ObermüllerBOBeate Obermüller
- Angela HorvathAHAngela Horvath
- Giovanny Rodriguez-BlancoGRGiovanny Rodriguez-Blanco
- Patricia FuchsPFPatricia Fuchs
- Wolfram MiekischWMWolfram Miekisch
- Barbara MittlBMBarbara Mittl
- Christina FlucherCFChristina Flucher
- Holger TillHTHolger Till
- Georg SingerGeorg Singer
Open Access
- 29 November 2023
- Vol. 15 (23) , 4949
Abstract
Pediatric short bowel syndrome (SBS) is a rare condition characterized by a massive loss of the small intestine, leading to the inability to meet nutritional requirements without the use of parenteral or enteral supplementation. SBS causes profound alterations in the intestinal microbiome and metabolome. The aim of this study was a detailed assessment of the intestinal microbiome and metabolome in a murine model of SBS. We performed a 60% proximal small bowel resection versus a sham operation in C57BL/6 mice. Four weeks postoperatively, the microbial communities of different intestinal segments (jejunum, ileum, colon) and stool were assessed by 16S rRNA gene sequencing. Bile acids in serum and stool and volatile organic compounds (VOCs) in the fecal headspace were assessed using LC-MS and GC-MS techniques. The α-diversity of the different intestinal segments did not significantly differ between the two groups. β-diversity significantly differed between sham and SBS mice. While in the jejunum, Faecalibaculum was significantly increased in SBS animals, a significant reduction in Lactobacillus and Sporosarcina was detected in the ileum of SBS mice. In the colon of SBS mice, a significant decrease in Ruminococcaceae and a significant increase in Proteobacteria such as Faecalibaculum and Escherichia-Shigella were found. Serum levels of deoxycholic, taurocholic and taurochenodeoxycholic acids were significantly higher in the SBS group. Of the 29 VOCs tested, hexane, isoflurane and pentane were significantly higher in the SBS group, and pyrrole was significantly lower. We were able to show that SBS causes shifts in the murine intestinal microbiome and metabolome including serum BAs and fecal VOCs.Keywords
Funding Information
- Doctoral School “Molecular Medicine and Inflammation” of the Medical University of Graz
This publication has 63 references indexed in Scilit:
- Role of Probiotics in Short Bowel Syndrome in Infants and Children—A Systematic ReviewNutrients, 2013
- The SILVA ribosomal RNA gene database project: improved data processing and web-based toolsNucleic Acids Research, 2012
- Solid-Phase Microextraction and the Human Fecal VOC MetabolomePLOS ONE, 2011
- Drastic changes in fecal and mucosa-associated microbiota in adult patients with short bowel syndromeBiochimie, 2010
- Pediatric short-bowel syndrome: the cost of comprehensive careThe American Journal of Clinical Nutrition, 2008
- An analysis of volatiles in the headspace of the faeces of neonatesJournal of Breath Research, 2008
- Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal diseaseThe FASEB Journal, 2007
- Causes and Management of Intestinal Failure in ChildrenGastroenterology, 2006
- Breath alkanes determination in ulcerative colitis and Crohn's diseaseDiseases of the Colon & Rectum, 1999
- Determination of inflammatory bowel disease activity by breath pentane analysisDiseases of the Colon & Rectum, 1993